MHC-I presents viral antigens for CD8+ cytotoxic T lymphocyte (CTL) activation. Upon activation, these cells kill and eliminate virus-infected cells throughout the human body. Several viruses have ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

Moncef Slaoui, the former head of the Trump administration's Operation Warp Speed, says he's "cautiously optimistic" about how well existing vaccines will hold up against omicron, the latest ...

Thea van de Mortel teaches into the Griffith University Master of Infection Prevention and Control program. You’ve tested negative for COVID using a rapid antigen test (RAT), but are a close contact ...

Throughout the pandemic, the virus that causes COVID-19 has been evolving fast, blindsiding the world with one variant after another. But the World Health Organization hasn't given a SARS-CoV-2 ...

The FDA, on Oct 12, expanded the eligibility of the granted emergency use authorization (EUA) to Omicron BA.4/BA.5-adapted bivalent vaccines developed by Pfizer PFE/BioNTech BNTX and Moderna MRNA. The ...

Investigators determined that the BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant In an analysis of COVID-19 ...

Neil Mabbott does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) ...

Data support request for Emergency Use Authorization of a 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older Companies have rapidly ...